SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,242.70 |
| Enterprise Value ($M) | 2,266.80 |
| Book Value ($M) | 292.28 |
| Book Value / Share | 0.48 |
| Price / Book | 7.67 |
| NCAV ($M) | 245.39 |
| NCAV / Share | 0.41 |
| Price / NCAV | 9.14 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -0.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.74 |
| Current Ratio | 2.89 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 398.06 |
| Assets | 444.95 |
| Liabilities | 152.67 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Rtw Investments, Lp | 7.30 | ||
| 13G/A | Deep Track Capital, LP | 1.26 | -74.39 | |
| 13G/A | Ra Capital Management, L.p. | 9.99 | 14.82 | |
| 13G | Vanguard Group Inc | 5.26 | 85.16 | |
| 13G/A | BlackRock, Inc. | 7.80 | 54.70 | |
| 13G/A | State Street Corp | 4.72 | 30.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,456,432 | 9,163,912 | 26.81 | |
| 1,732,209 | 9,008,802 | 19.23 | |
| 2,848,259 | 10,904,798 | 26.12 | |
| 2,269,647 | 10,291,805 | 22.05 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FDMT – 4D Molecular Therapeutics, Inc. | FGEN – FibroGen, Inc. |
| GBIO – Generation Bio Co. | GILD – Gilead Sciences, Inc. |
| GLUE – Monte Rosa Therapeutics, Inc. |